Showing results (31-40 of 92) with videos related to
Sort By:
Pageof 10
Investigational New Drugs|August 11, 2010
A phase I dose escalation study of TTI-237 in patients with advanced malignant solid tumorsAndrea Wang-Gillam, Susanne M Arnold, Ronald M Bukowski, et al.American Journal of Clinical Oncology|February 6, 2009
A phase I dose-escalation study of SR271425, an intravenously dosed thioxanthone analog, administered weekly in patients with refractory solid tumorsA Craig Lockhart, Emiliano Calvo, Anthony W Tolcher, et al.Cancer Chemotherapy and Pharmacology|August 19, 2015
A phase I open-label trial evaluating the cardiovascular safety of regorafenib in patients with advanced cancerRobin L Jones, Johanna C Bendell, David C Smith, et al.Journal of Neuro-Oncology|March 12, 2016
A phase I study to repurpose disulfiram in combination with temozolomide to treat newly diagnosed glioblastoma after chemoradiotherapyJiayi Huang, Jian L Campian, Amit D Gujar, et al.Investigational New Drugs|May 9, 2008
Phase I trial of pemetrexed plus oxaliplatin administered every other week in patients with metastatic cancerDaniel G Stover, A Craig Lockhart, Jordan D Berlin, et al.Journal of Neuro-Oncology|January 29, 2018
Final results of a phase I dose-escalation, dose-expansion study of adding disulfiram with or without copper to adjuvant temozolomide for newly diagnosed glioblastomaJiayi Huang, Jian L Campian, Amit D Gujar, et al.Investigational New Drugs|August 19, 2017
Effect of alisertib, an investigational aurora a kinase inhibitor on the QTc interval in patients with advanced malignanciesXiaofei Zhou, John Nemunaitis, Shubham Pant, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 22, 2016
Neoadjuvant Chemotherapy versus Chemoradiation Prior to Esophagectomy: Impact on Rate of Complete Pathologic Response and Survival in Esophageal Cancer PatientsPamela Samson, Clifford Robinson, Jeffrey Bradley, et al.Cancer Chemotherapy and Pharmacology|September 18, 2016
Phase 1 study evaluating the safety and pharmacokinetics of pralatrexate in relapsed/refractory advanced solid tumors and lymphoma patients with mild, moderate, and severe renal impairmentKevin R Kelly, Nashat Gabrail, Steven Weitman, et al.Cancer Chemotherapy and Pharmacology|May 23, 2007
A phase II study of milataxel: a novel taxane analogue in previously treated patients with advanced colorectal cancerRamesh K Ramanathan, Joel Picus, Haralambos Raftopoulos, et al.Pageof 10